Embigin (EMB), a transmembrane glycoprotein of the immunoglobulin superfamily (35), is involved in the occurrence and development of prostate cancer, pancreatic cancer and breast cancer, and is associated with poor prognosis in cancer patients (36–38), but not in reports of gastric cancer. The gene discussed is EMB; the disease is prostate cancer.